Shilpa Medicare Approves Q3 FY26 Standalone & Consolidated Results; Reconstitutes Audit Committee
Shilpa Medicare Limited approved its unaudited standalone and consolidated financial results for Q3 FY26. Standalone net profit was ₹1,593.46 lakhs and consolidated net profit attributable to owners was ₹4,875.16 lakhs for the quarter. The company also reconstituted its Audit Committee, inducting Mr. Ashraf Allam.
The announcement includes the financial results for the quarter and nine months, which are material for investors. The reconstitution of the Audit Committee is also a significant corporate governance event.
The announcement reports financial results and a board meeting outcome, which are routine corporate events. While the results themselves might have positive or negative implications, the announcement itself is factual and does not contain strong positive or negative indicators.
Shilpa Medicare Limited announced the outcome of its Board Meeting held on February 06, 2026, where the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, were approved. The company also approved the reconstitution of its Audit Committee with the induction of Mr. Ashraf Allam as a member.
The Board meeting commenced at 12:30 p.m. (IST) and concluded at 2:30 p.m. (IST). The approved financial results, along with the Limited Review Report from the Statutory Auditors, have been submitted. The reconstituted Audit Committee now includes Mr. Hetal Madhukant Gandhi as Chairman, Dr. Anita Bandyopadhyay as Member, Mr. Om Prakash Innani as Member, and Mr. Ashraf Allam as Member.
The standalone results for the quarter ended December 31, 2025, show a total income of ₹17,699.27 lakhs and a net profit of ₹1,593.46 lakhs. For the nine months ended December 31, 2025, the total income was ₹43,909.15 lakhs with a net profit of ₹6,746.01 lakhs.
In the consolidated results for the quarter ended December 31, 2025, the total income stood at ₹41,054.10 lakhs, with a profit attributable to owners of the Parent Company of ₹4,875.16 lakhs. For the nine months ended December 31, 2025, the total income was ₹111,010.04 lakhs and the profit attributable to owners of the Parent Company was ₹13,553.46 lakhs.
What to do with a filing like this
Shilpa Medicare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shilpa Medicare Limited. Read the original for the full detail.